Prognostic factors in patients with bulky stage IB or IIA cervical carcinoma undergoing neoadjuvant chemotherapy and radical hysterectomy

Gynecologic Oncology

Volumn 64, Issue 3, 1997, Pages 456-462

  Lai, Chyong Huey ^a,b   Hsueh, Swei ^b   Chang, Ting Chang ^a   Tseng, Chih Jen ^a   Huang, Kuan Gen ^a   Chou, Hung Hsueh ^a   Chen, Shiow Meei ^a   Chang, Ming Fang ^a   Shum, Hin Cheung ^b  

^a CHANG GUNG UNIVERSITY   (Taiwan)

^b CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; CISPLATIN; DNA; SQUAMOUS CELL CARCINOMA ANTIGEN; VINCRISTINE;

ADULT; ARTICLE; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CANCER STAGING; COUGHING; FEMALE; FLOW CYTOMETRY; HISTOLOGY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPHEDEMA; MAJOR CLINICAL STUDY; PLOIDY; PRIORITY JOURNAL; PROGNOSIS; RADICAL HYSTERECTOMY; SURVIVAL RATE; TUMOR VOLUME; UTERINE CERVIX CARCINOMA;

EID: 0031106296     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.1996.4603     Document Type: Article

References (23)

1. 1. Piver MS, Chung WS: Prognostic significance of cervical lesion size and pelvic node metastases in cervical carcinoma. Obstet Gynecol 46:507-510, 1975
2. 2. Burghardt E, Pickel H: Local spread and lymph node involvement in cervical cancer. Obstet Gynecol 52:138-145, 1978
3. 3. Chung CK, Nahhas WA, Stryker JA, Curry SL, Abt AB, Mortel R: Analysis of factors contributing to treatment failures in stages IB and IIA carcinoma of the cervix. Am J Obstet Gynecol 138:550-556, 1980
4. 4. Alvarez RD, Soong SJ, Kinney WK, Reid GC, Schray MF, Podratz KC, Morley GW, Shingleton HM: Identification of prognostic factors and risk groups in patients found to have nodal metastasis at the time of radical hysterectomy for early-stage squamous carcinoma of the cervix. Gynecol Oncol 36:130-135, 1989
5. 5. Delgado G, Bundy B, Zaino R, Sevin BU, Creasman WT, Major F: Prospective surgical-pathological study of disease-free interval in patients with stage IB squamous cell carcinoma of the cervix: A Gynecologic Oncology Group study. Gynecol Oncol 38:352-357, 1990
6. 6. Bloss JD, Berman ML, Mukhererjee J, Manetta A, Emma D, Ramsanfhani NS, Disaia PJ: Bulky stage IB cervical carcinoma managed by primary radical hysterectomy followed by tailored radiotherapy. Gynecol Oncol 47:21-27, 1992
7. 7. Weems DH, Mendedhall WM, Bova FJ, Marcus RB, Morgan LS, Million RR: Carcinoma of the intact uterine cervix IB-IIA-B, ≥6 cm in diameter: Irradiation alone vs preoperative irradiation and surgery. Int J Radiat Oncol Biol Phys 11:1911-1914, 1985
8. 8. Perez CA, Grigsby PW, Camel HM, Galakatos AE, Mutch D, Lockett MA: Irradiation alone or combined with surgery in stage IB, IIA, and IIB carcinoma of uterine cervix: Update of a nonrandomized comparison. Int J Radiat Oncol Biol Phys 31:703-716, 1995
9. 9. Sardi JE, DiPaola GR, Cachau A, Ortiz OC, Sananes C, Giaroli A, Martins D, Peluffo M: A possible new trend in the management of the carcinoma of the cervix uteri. Gynecol Oncol 25:139-149, 1986
10. 10. Kim DS, Moon H, Hwang YY, Cho SH: Preoperative adjuvant chemotherapy in the treatment of cervical cancer stage Ib, IIa, and IIb with bulky tumor. Gynecol Oncol 29:321-332, 1988
11. 11. Panici PB, Scambia G, Baiocchi G, Greggi S, Ragusa G, Gallo A, Conte M, Battaglia F, Laurelli G, Rabitti C, Capelli A, Mancuso S: Neoadjuvant chemotherapy and radical surgery in locally advanced cervical cancer. Cancer 67:372-379, 1991
12. 12. Dottino PR, Plaxe SC, Beddoe AM, Johnston C, Cohen CJ: Induction chemotherapy followed by radical surgery in cervical cancer. Gynecol Oncol 40:7-11, 1991
13. 13. Namkoong SE, Park JS, Kim JW, Bae SN, Han GT, Lee JM, Jung JK, Kim SJ: Comparative study of the patients with locally advanced Stage I and II cervical cancer treated by radical surgery with and without preoperative adjuvant chemotherapy. Gynecol Oncol 59:136-142, 1995
14. 14. Eddy GL, Manetta A, Alvarez RD, William L, Creasman WT: Neoadjuvant chemotherapy with vincristine and cisplatin followed by radical hysterectomy and pelvic lymphadenectomy for FIGO stage IB bulky cervical cancer: A Gynecologic Oncology Group pilot study. Gynecol Oncol 57:412-416, 1995
15. 15. Sardi J, Sananes C, Giaroli A, Bayo J, Rueda NG, Vighi S, Guardado N, Paniceres G, Snaidas L, Vico C, Paola G: Results of a prospective randomized trial with neoadjuvant chemotherapy in stage IB, bulky, squamous carcinoma of the cervix. Gynecol Oncol 49:156-165, 1993
16. 16. Thomas GM: Is neoadjuvant chemotherapy a useful strategy for the treatment of stage IB cervix cancer? Gynecol Oncol 49:153-155, 1993
17. 17. Chang HC, Lai CH, Chou PC, Tseng CJ, Chang TC, Hsueh S, Ho YS, Soong YK: Neoadjuvant chemotherapy with cisplatin, vincristine, and bleomycin and radical surgery in early-stage bulky cervical carcinoma. Cancer Chemother Pharmacol 30:281-285, 1992
18. 18. Piver MS, Rutledge F, Smith JP: Five classes of extended hysterectomy for women with cervical cancer. Obstet Gynecol 44:265-272, 1974
19. 19. World Health Organization: WHO Handbook for Reporting Results of Cancer Treatment, Offset Publication No 48. Geneva, WHO, pp 22-27, 1979
20. 20. Lai CH, Hsueh S, Huang MY, Chang MF, Soong YK: The uses and limitations of DNA flow cytometry in stage IB or II cervical carcinoma. Cancer 72:3655-3662, 1993
21. 21. Mantel N: Evaluation of survival data and two rank order statistics arising in its consideration. Cancer Chemother Rep 50:163-170, 1966
22. 22. Bloss JD, Lucci JA III, DiSaia PJ, Mametta A, Schiano MA, Ramsinghani N, Berman ML: A phase II trial of neoadjuvant chemotherapy prior to radical hysterectomy and/or radiation therapy in the management of advanced carcinoma of the uterine cervix. Gynecol Oncol 59:105-110, 1995
23. 23. Barter JF, Soong SJ, Shingleton HM, Hatch KD, Orr JW: Complications of combined radical hysterectomy-postoperative radiation therapy in women with early-stage cervical cancer. Gynecol Oncol 32:292-296, 1989